Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 7Lung Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Mesothelioma, Malignant 3Head and Neck Neoplasms 3Glioblastoma 3Gallbladder Neoplasms 3Brain Neoplasms 3Bile Duct Neoplasms 3Astrocytoma 3Pleural Diseases 2Pancreatic Neoplasms 2Mouth Neoplasms 2Laryngeal Neoplasms 2Gliosarcoma 2Glioma 2Central Nervous System Neoplasms 2Urinary Bladder Neoplasms 1Tongue Neoplasms 1Solitary Fibrous Tumor, Pleural 1Small Cell Lung Carcinoma 1Recurrent Head and Neck Carcinoma 1Precancerous Conditions 1Pleural Effusion, Malignant 1Pituitary Neoplasms 1Photosensitivity Disorders 1Oropharyngeal Neoplasms 1Optic Nerve Glioma 1Oligodendroglioma 1Non-Muscle Invasive Bladder Neoplasms 1

Interventions

Photochemotherapy 1Drug Therapy 1Dihematoporphyrin Ether 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Epitheliod Malignant Pleural Mesothelioma × Dihematoporphyrin Ether × Clear all
NCT02153229 2025-12-26

MPM-PDT

Abramson Cancer Center at Penn Medicine

Phase 2 Active not recruiting
52 enrolled
Other solid neoplasmThoracic

Epitheliod Malignant Pleural Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡